Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
about
Place of mTOR inhibitors in management of BKV infection after kidney transplantationBK polyoma virus infection and renal disease in non-renal solid organ transplantationPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Unraveling the Role of Allo-Antibodies and Transplant InjuryPolyomaviruses and disease: is there more to know than viremia and viruria?The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationThe impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantationLeflunomide: a drug with a potential beyond rheumatologyPolyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data.Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft RejectionPre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.Graft Function and Intermediate-Term Outcomes of Kidney Transplants Improved in the Last Decade: Analysis of the United States Kidney Transplant Database.Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipientsUreteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney TransplantationCanadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.Immunoglobulin G, A, and M responses to BK virus in renal transplantation.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodiesImpact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infectionThymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease.Polyomavirus nephropathy in kidney transplantation.Strategies for minimizing immunosuppression in kidney transplantation.BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experienceBK virus: opportunity makes a pathogen.Clinical and pathological features of kidney transplant patients with concurrent polyomavirus nephropathy and rejection-associated endarteritis.Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients.Polyomavirus-associated nephropathy: update on BK virus-specific immunity.BK virus nephropathy in a heart transplant recipient: case report and review of the literature.BK virus infection in transplant recipients: an overview and update.Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat.Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients
P2860
Q26751556-99CEBF7D-27F8-4058-8557-B937E35BAA93Q26764877-D5FDB89B-95CA-4233-978A-18066F0FB6E2Q26826085-569A6E4D-28DD-4B3C-B927-2CAF63E19A30Q28069336-1DCC496C-7A7E-46F9-8CF0-A0E36C4F8F9EQ28081350-5C4D1992-F986-4C22-9174-FFE5FFB88070Q28085440-44ED5B38-373A-49F3-92E5-986476942E58Q28292658-D4E3777E-947B-458B-A34B-7E5A1F0BDA4DQ28294236-CFAE8DA5-12FD-451D-97C9-CEDD452DB45BQ30422449-B17CB5BB-3722-4486-B352-42A09769DEE6Q31095760-9F91078A-C6E6-4BC5-AD8B-D1ABBB018CDEQ33376066-EE0F095B-8A41-4077-A96C-07CCDB5CC96EQ33694700-6F46A33D-4803-4443-8C75-B3DA0942E690Q33745763-F59BBF77-5A1F-49C6-AB34-5158B444ED9BQ33779071-555FDDA0-CD6C-467D-8407-167171FBE7F1Q34235141-2D74310B-C23F-4224-91C2-69555AE352BCQ34257069-908ED5B8-160F-4F4E-87F2-3C292B046981Q34261036-9C81DB64-30FB-4E8B-861A-9CA80C62D463Q34337472-FF8660E8-618D-436F-9BC2-F37985374BAEQ34786760-BFFED207-3453-4025-9BDA-DCFE7EAA3627Q34909392-A1D3D94A-AB5B-429A-858E-4D5618FCA628Q35006676-062877A8-5B1D-4BBB-9CD5-0456702C2D8CQ35023405-94008694-C46D-4E40-997F-3AF7FB7BD347Q35099077-5C703384-39D9-4815-815F-C884DAE0358BQ35228551-6DB498BD-5C89-4448-9284-80A5F90AA9C3Q35598869-3240E0BF-6ECB-42A4-82E8-462DDD5D4481Q35781366-C36AFE3F-10C9-4F50-B297-31DBC1233447Q35841374-158EFC40-2C2D-4A10-9D1A-259BB6FA4D05Q35990853-6D00C689-49D5-4E2A-8082-77B52689502DQ36006095-74780E48-D86E-4A36-8EE8-FAC2C6BA5FCBQ36014205-FD2B31D9-F132-410C-B716-DED77A2CB4D5Q36188861-2FB64B70-7B0B-49FC-AE79-949D932EFABCQ36400852-96EB136A-47D9-4668-A3E7-B104889A72EAQ36492408-2543F487-45FC-4A6B-9DCD-B57C83D858AEQ36492414-1238E990-85CC-43B1-98E0-788D7B72F729Q36492423-40876BB9-9A08-4476-BEFE-9DB4E5B7BCB6Q36505713-CD4BDA39-C9A6-4587-9E3D-E4ED9AFCCF4FQ36537931-34138D58-391E-42FD-B608-1D38AD649FBEQ36642850-3A10A0CA-442A-42BB-8390-B7876BE99332Q36846488-29DF1E24-70B7-4282-825D-40D0355DC934Q36933028-841E8016-B281-4F1C-8D8F-B1118B7FE129
P2860
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@en
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@nl
type
label
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@en
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@nl
prefLabel
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@en
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@nl
P2093
P1476
Clinical course of polyoma virus nephropathy in 67 renal transplant patients.
@en
P2093
Anne Wiland
Charles B Cangro
Cinthia B Drachenberg
David K Klassen
Emilio Ramos
Eugene Schweitzer
John C Papadimitriou
Matthew R Weir
Omar Hamze
Ravinder Wali
P304
P356
10.1097/01.ASN.0000023435.07320.81
P577
2002-08-01T00:00:00Z